Pharmaceutical Industry Information Portal


All posts by tag


Sanofi to cut out-of-pocket insulin costs to $35 for U.S. patients

French drugmaker Sanofi  said on Wednesday uninsured diabetes patients in the United States will pay no more than $35 for 30-day supply of insulin,...

Biocon Biologics gets EMA’s backing for Inpremzia

Biocon Biologics Ltd. (BBL), a subsidiary of Biocon Ltd., announced today the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has...

Breakthrough research of UNN chemists to help diabetic patients

Federal Service for Intellectual Property (Rospatent) has summed up the results of the year 2021. According to RIA Novosti, the head of Rospatent Grigory...

Walmart Revolutionizes Insulin Access

Walmart announced the launch of the first-ever private brand analog insulin, which will revolutionize the access and affordability to diabetes care by offering customers...

Expert Articles